The vitamin market remains largely subdued, though signs of change are emerging. While Vitamin E and D3 continue to face weak demand and price spreads, Vitamins A and B3 show early signs of stabilisation and renewed contracting interest. Q4 activity is picking up, but not uniformly across all products. Highlights: Vitamin E 50%: The market remains weak despite very low prices and favourable availability. Buyers are cautious, and Q4 is only partially contracted.
Vitamin A 1000: Signs of pr
Get full access to all stories on All About Feed
This Premium article is exclusively available for subscribers.
Obtain insights from exclusive interviews
Dive into articles covering trending industry topics
Stay up-to-date on the market trends
All the news is brought to you by experienced editors and experts from around the world